Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Nat Cancer. 2021 Feb 15;2:357–365. doi: 10.1038/s43018-021-00172-1

Table 2:

Patient characteristics

Characteristic Mutation Carriers, N = 1381 Non-Mutation Carriers, N = 6131 Overall, N = 751 p-value2
Sex 0.65
 Female 67 (49%) 282 (46%) 349 (46%)
 Male 71 (51%) 331 (54%) 402 (54%)
Age at diagnosis (years) 7.4 ± 6.8 (0.0–19.0) 8.4 ± 6.3 (0.0–19.0) 8.2 ± 6.4 (0.0–19.0) 0.11
Multiple diagnoses 0.0001519
 No 124 (90%) 595 (97%) 719 (96%)
 Yes 14 (10%) 18 (3%) 32 (4%)
Deceased
 No 117 (85%) 519 (85%) 636 (85%)
 Yes 21 (15%) 94 (15%) 115 (15%)

1

Statistics presented: n (%); mean ± SD (minimum-maximum)

2

Statistical tests performed: chi-square test of independence and t-test, all two-sided